An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer

Published:2014-04-18 Issue:1 Volume:70 Page:521-527
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Xu Song,Zhang Zhengyu,Ogawa Osamu,Yoshikawa Takeshi,Sakamoto Hiromasa,Shibasaki Noboru,Goto Takayuki,Wang Liming,Terada Naoki

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry,General Medicine,Biophysics

Link

http://link.springer.com/content/pdf/10.1007/s12013-014-9951-2.pdf

Reference24 articles.

1. Gronberg, H. (2003). Prostate cancer epidemiology. Lancet, 261, 859.

2. Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10.

3. Terada, N., Shimizu, Y., Kamba, T., et al. (2010). Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Research, 70, 1606.

4. Xin, X., Majumder, M., Girish, G. V., et al. (2012). Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Laboratory Investigation, 92, 1115.

5. Takita, M., Inada, M., Maruyama, T., et al. (2007). Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. FEBS Letters, 581, 565.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4;Genes & Diseases;2023-11

2. A novel role for PGE₂-EP₄ in the developmental programming of the mouse ductus arteriosus: consequences for vessel maturation and function;American Journal of Physiology-Heart and Circulatory Physiology;2023-10-01

3. Quantification of Grapiprant and Its Stability Testing under Changing Environmental Conditions;Biomedicines;2022-11-05

4. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer;Seminars in Cancer Biology;2022-11

5. Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression;Acta Medica Nicomedia;2022-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3